Please be aware that some of the information / intended uses / configurations / accessories mentioned here are not available in your country. For more information contact your local distributor.
In the EU:
EMSCULPT NEO is intended for treatment of obesity by fat reduction through neuromuscular stimulation, radiofrequency induced lipolysis and increase of the blood flow. BTL EMSCULPT is intended for treatment of obesity by fat reduction through neuromuscular stimulation and increase of the blood flow. BTL EMSELLA is intended to provide pelvic floor muscle strengthening for treatment of urinary incontinence in male and female patients. The Exilis Ultra 360 is intended for treatment of obesity by means of controlled reduction of fat cells, induced by radiofrequency field in cooperation with ultrasound and for treatment of sexual dysfunction after vaginal delivery by means of improvement of vaginal laxity.Vanquish / BTL Vanquish ME is a non-invasive therapeutic device intended for the treatment of obesity by means of fat reduction achieved through deep tissue heating and enhancement of blood flow and metabolism by high-frequency electromagnetic field. EMTONE is a radio-frequency combined with targeted pressure energy device for treatment of obesity and localized obesity by fat reduction, skin laxity treatment, skin regeneration, treatment of gynoid lipodystrophy, alleviation of pain and alleviation of muscle spasms. BTL-6000 X-Wave Optimal is a non-invasive therapeutic device using acoustic waves in order to stimulate local biological response of the treated tissue. Biological response includes decrease of local pain sensation, muscle relaxation and increase of blood microcirculation resulting in local metabolism enhancement and local trophic improvement. The BTL-6000 X-Wave Optimal can be used to treat painful conditions of musculoskeletal system such as chronic tendinopathies, insertional pain, trigger points and other painful syndromes and for treatment of degenerative and overuse conditions of musculoskeletal system such as arthrosis, arthritis, calcifications and chronic inflammations. BTL®, EXILITE®, EXILIS®, VANQUISH®, UNISON®, CELLUTONE®, EMSCULPT®, EMSCULPT NEO®, EMSELLA®, EMBODY®, EMTONE® and HIFEM® are registered trademarks in the United States of America, the European Union or other countries. Trademarks EMSCULPT, EMSELLA, EMBODY, EMTONE and HIFEM are parts of EM™ Family of products. Products, the methods of manufacture or the use may be subject to one or more U.S. or foreign patents or pending applications. *Data on file.
1Abdominal toning and reduction of subcutaneous fat with combination of novel radiofrequency treatment and HIFEM procedure - MRI scan study. Jacob C. et al. Presented at ASDS 2020 Virtual Meeting.
2Radiofrequency heating and HIFEM delivered simultaneously - the first shamcontrolled randomized trial. Katz B. et al. Presented at ASDS 2020 Virtual Meeting.
3Ultrasound evaluation of the simultaneous RF and HIFEM treatments on human fat tissue. Denkova R. Source: U.S. Food and Drug Administration. 510(k) Premarket Notification: K192224. Published online on December 5, 2019.
Results and patient experience may vary. As with any medical procedure, ask your doctor if the procedure is right for you.
This site is not intended for US customers. US customers, click here.
We are protecting our clients‘ personal data responsibly. Read more.
© 2020, BTL Group of Companies. All rights reserved. | sales@btlnet.com | Sitemap |
Terms of Use
| Privacy Statement
| GDPR
